Neuren Pharmaceuticals Limited (ASX:NEU)
Australia · Delayed Price · Currency is AUD
13.44
+0.73 (5.74%)
At close: Feb 26, 2026
Revenue by Segment
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
|---|
| 213.24M | 231.93M | 14.55M | - | - | | | | | |
Commercial Products Growth | -8.06% | 1493.66% | - | - | - | | | | | |
| - | - | - | 3.20M | 717.00K | | | | | |
Pharmaceutical Products Growth | - | - | - | 345.89% | 44.85% | | | | | |
| 213.24M | 231.93M | 14.55M | 3.20M | 717.00K | | | | | |
| -8.06% | 1493.66% | 355.21% | 345.89% | 44.85% | | | | | |
Source: S&P Global Market Intelligence.
